TUNISIAN-BELGIAN PAN-ARAB CONGRESS M E E T I N G

THE ARAB SOCIETY
TUNISIAN SOCIETY
OF NEPHROLOGY
OF NEPHROLOGY
AND RENAL TRANSPLANTATION
st
th
PAN-ARAB
CONGRESS
TUNISIAN-BELGIAN
MEETING
PANARAB CONGRESS OF TRANSPLANTATION
The 27,28 and 29th of November 2014
Items:
Hotel Royal Kenz
Guest :
Immunosuppressive therapy
Specificities in pediatric kidney transplantation
Immunologic monitoring in kidney transplantation
Update in BANFF classification
Surgical features in kidney transplantation
Immunosuppressive therapy and liver
Abstract Submission: before 30th September 2014
Exclusively via the E-mail
Pct.stn@gmail.com
Congress Secretary
Department of Nephrology –Sahloul hospital 4054 – Sousse - TUNISIA
 : (+216) 73369430 - 73369411 Post 1558 -  : (+216) 73367451
E-mail: pct.stn@gmail.com
Symposium
SANOFI - NOVARTIS
Dear Colleague,
We are proud to announce the The 8th Tunisia – Belgium Meeting and the 1st Panarab
th
congress of Transplantation taking place in Soussa, Tunisia from the 27 to the 29 of
November 2014.
th
The 8 Tunisia – Belgium Meeting and the Panarab congress of Transplantation is a
scientific event hosted by the Tunisian Society of Nephrology in partnership with the Arab
Society of Nephorology and Renal Transplantation (ASNRT).
During the rich program, our distinguished international speakers provide updates and
global advancement of kidney transplantation.
This scientific event will bring together practicing physicians, academics, scientists involved
in organ transplantation offering a global forum for an exchange of science and medical
strategies aligned with local and regional reflections under the overall congress theme.
The main Key scientific Items are:
•
Immunosuppressive therapy
•
Specificities in pediatric kidney transplantation
•
Immunologic monitoring in kidney transplantation
•
Update in BANFF classification
•
Surgical features in kidney transplantation
•
Immunosuppressive therapy and liver
th
The 8 Tunisia – Belgium Meeting and the ASNRT aim to advance the education of
physicians and other professionals, support the development of renal research, and
facilitate the delivery of high-quality healthcare worldwide.
•
For more information about The 8th Tunisia – Belgium Meeting and the 1st Panarab
congress of Transplantation, please visit this website : www.stn-nephro.org
•
For sponsorship and exhibitor opportunities, please email pct.stn@gmail.com
Coordinator
PHD Abdellatif Achour
CONGRES PANARABE DE TRANSPLANTATION /
PANARAB CONGRESS OF TRANSPLANTATION
WELCOME MESSAGE
The organizing committee of the 8th … Tunisia – Belgium meeting and the
first Panarab congress of Transplantation is pleased to invite you to leading
congress on transplantation, biology and medicine which will be held in
Sousse- Tunisia from 28 to 29 th of November 2014.
SOUSSE is an exceptional location of this congress.
This meeting will provide a wonderful form for you in order to refresh your
knowledge base and explore the innovations in especially kidney
transplantation, biology and medicine. It’s an opportunity to meet, discuss
and interact with the leading scientists, physicians and surgeons in the field
of transplantation.
We hope you will join us for a symphony of outstanding, science and take a
little extra time to enjoy the spectacular and unique beauty of this region.
With warmest regards
Pr ACHOUR Abdellatif
CONGRES PANARABE DE TRANSPLANTATION /
PANARAB CONGRESS OF TRANSPLANTATION
Programme scientifique Préliminaire / Preliminary scientific Program
Dates : 27, 28 et 29 Novembre 2014
Dates: the 27, 28 and 29 of November 2014
Jeudi 27/11/2014
Thursday the 27 November /2014
Après-midi / Afternoon
Accueil des participants et Inscriptions
Welcome and Registration
Vendredi 28/11/2014
Friday the 28 November /2014
Matin
Morning
8h 30 - 9h
: Cérémonie d’ouverture / Opening Ceremony
Mot d’ouverture des présidents / Welcome message of presidents
ERA-EDTA : Prof Raymond VANHOLDER
TSN : Prof Jamil HACHICHA
ASNRT : Prof Saeed El GHAMDY , MOHAMED BAKR
9h - 10h 30 : Conférences plénières / Plenary conferences
9h - 9h 30 : Recent Advances in Transplantation (M MASRI)
9h 30 - 10h : Particularités de la transplantation rénale chez le sujet âgé
Features and specificities of kidney transplantation in the elderly (M GHONIEMAT)
10h - 10h 30 : Trends in induction therapy to cover important issues and sure to focus on thy
moglobulin (M BAKR)
10h 30- 11h : Pause Café
Coffee Break
11h - 11h 30 : Immunologic monitoring (M MASRI)
11h 30 - 12h : Transplant Bone Disease (S EL GHAMDY)
12h - 13h : Communications Libres
Free communications
13h - 14h : Déjeuner - Lunch
Après midi
After noon
14h - 16h :
Controverse / A controversy
14h - 15h : Controverse : Quelle technique d’implantation du greffon Intra péritonéale (Prof A
SHOKEIR )/Extra péritonéale (M. JAIDANE)
14 - 15h : A controversy : Which technique (surgical method) of graft implantation Intra peritoneal
(Prof A SHOKEIR)/ Extra peritoneal (M. JAIDANE)
15h - 15h 30 : Protocole d’immunosuppression chez l’enfant (M BAKR)
Immunosuppression regimen in children (M BAKR)
15h 30 - 16h : Greffe pédiatrique à partir de donneur vivant (T GARGAH)
Pediatric transplant from living donor
16h - 16h 30 : Pause Café
Coffee Break
16h 30 - 18h 30 : Symposium : SANOFI
Controverse / A controversy
Traitement Immunosuppresseur d’induction : Anticorps poly clonaux ( ……) versus monoclonaux (P
PEETERS)
Induction immunosuppressive treatment : Poly clonal versus (……..) monoclonal anti bodies (P.PEETERS)
Traitement Immunosuppresseur d’entretien : Minimisation de l’Immunosuppression / augmentation de
l’Immunosuppression
Immunosuppressive Maintenance Treatment : Minimisation immunosuppression / increasing
Immunosuppression : the controversy of immunosuppression (S EL GHAMDY / R DERANIA)
Samedi 29/11/2014
Saturday, 11/29/2014
9h - 10h : Immunosuppression et foie I / Immunosuppression and liver
1/ Quels Immunosuppresseurs utiliser en cas de maladie hépatique ou d’hépatite virale ( P.PEETERS)
What Immunosuppression treatment can we use in hepatic and viral disease (P.PEETERS)
2/ Hépatopathie post greffe rénale : quelle conduite? (N KAMAR)
Hepatopathy after kidney transplantation : Which therapeutic attitude? (N KAMAR)
10h - 10h 45 : BANFF 2013 UP to date
Spécificités du rejet aigu humoral (LINA ASAAD)
Specificities of antibody mediated rejection (LINA ASAAD)
Cas Clinique / Clinical Case (RIM GOUCHA)
10h 45 - 11h :
Communications libres / Free Communications
11h - 11h 30
Pause café / Coffee break
11h 30 - 12h : Syndrome métabolique et transplantation rénale (F JARRAYA)
Metabolic syndrome and renal transplantation
12h - 13h 30 :
Symposium NOVARTIS
MMF and transplantation (NASSIM KAMAR).
CLOTURE/CONCLUSION
DEJEUNER/LUNCH
Call for Abstracts
Thank you for all your contributions to create an exceptional scientific program
Important Dates to Remember
Abstract submission closing date: 30th September, 2014
Authors will be notified (via email) about the Scientific Committee’s decision
from October 30th, 2014.
Abstract Submission Instructions
email: pct.stn@gmail.com.
Please read the instructions carefully, as abstracts submitted not according to these
instructions will not be accepted.
abstracts. Please contact the Congress Secretariat if you do not receive the
acknowledgement.
post or fax will not be accepted.
Abstract Format
1. Word limit is 300 words. Word limit of 300 words includes tables which must be in text
format, not graphic format.
2. Do not include figures or graphs with the abstract. Any figures or tables in graphic format
will not be published.
3. Abstract title must be in Title Case. Title should be brief and clearly indicate the content
of the abstract.
4. Author and co-author names [first name, middle initial(s), and surname] institutions, cities
and countries are to be typed in appropriate boxes. Do not include degrees or professional
titles (Dr, PhD, Prof, MD, etc.)
Abstract Content
Make the abstract as informative as possible. Conclusions must be supported by data.
Organise the body of the abstract as follows:
(a) objectives
(b) methods
(c) results
(d) conclusions
Use standard abbreviations generic drug names. Place unusual abbreviations or acronyms in
parentheses after first use. Do NOT identify author(s) or institution(s) in text.